MIT spin-out Bizon Labs emerged with a process-optimization strategy aimed at making lipid nanoparticle (LNP) manufacturing more reproducible at scale. The company said it focuses on physically optimizing LNP attributes through adapted mixing workflows and improved process control rather than relying solely on formulation chemistry tweaks, positioning its approach to support consistent product performance across production scales.